← Leaderboards
Erlinda Rose Ulloa
University Of California-Irvine
$1,026,191
Attributed
$1,026,191
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $205.4K · FY2020–24$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,026,191 · 1
By mechanism
K08$1,026,191 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Matthew Everett Griffin$1,711,019
- Manuela Raffatellu$10,626,800
Others in their field
Other Emerging Leaders on “Cell Wall”
- Terry Roemer · Prokaryotics, Inc.$7,866,387
- Magali Noval Rivas · Cedars-Sinai Medical Center$5,639,049
- Som Chatterjee · University Of Maryland Baltimore$4,311,836
- Brandon Lyon Jutras · Virginia Polytechnic Inst And St Univ$4,090,830
- Krishnakumar Kizhatil · Columbia University Health Sciences$4,080,371
- Tobias Doerr · Cornell University$3,917,047
Research focus
Cell WallCell SurfaceAnti-Bacterial AgentsCellsAntimicrobialAffinityAntibioticsAwardBacterial GeneticsAntibiotic TherapyBacterial ResistanceBactericideAntibiotic ResistanceBeta-LactamaseBindingBinding ProteinsBlood PlateletsBostonCaliforniaCareerBacterial InfectionsCell DeathCell MembraneCharacteristics
Grant awards (5)
Beta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune Clearance$205,111
K08 · FY2024 · AI · contact PI
Beta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune Clearance$205,176
K08 · FY2023 · AI · contact PI
Beta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune Clearance$205,240
K08 · FY2022 · AI · contact PI
Beta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune Clearance$205,302
K08 · FY2021 · AI · contact PI
Beta-Lactamase Inhibitors Sensitize Multidrug-Resistant Gram-negative Pathogens to Innate Immune Clearance$205,362
K08 · FY2020 · AI · contact PI